Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇹🇼 Taiwan

GlucoSure Advance II

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-47136487603C163
Basic UDI-DI Code
B-47136487603C163
Reference
S70335 S70350 S70512 S70513 S70514
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The GlucoSure ADVANCE II Blood Glucose Monitoring System is intended for quantitatively measurement of glucose in venous whole blood, neonatal whole blood, or capillary whole blood drawn from fingertips, palm, or forearm. It is intended for in vitro diagnostic use by people with diabetes or by health care professionals, as an aid to monitor glucose level in diabetes mellitus. It is not indicated for diagnosis or screening of diabetes.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS
W0101060101 GLUCOSE TEST STRIPS
W0201060102 BLOOD GLUCOSE METERS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL2100077-1

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all